BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3370743)

  • 1. The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits.
    Iven H; Brasch H
    Cancer Chemother Pharmacol; 1988; 21(4):337-42. PubMed ID: 3370743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cephalosporins increase the renal clearance of methotrexate and 7-hydroxymethotrexate in rabbits.
    Iven H; Brasch H
    Cancer Chemother Pharmacol; 1990; 26(2):139-43. PubMed ID: 2189590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance studies of methotrexate and 7-hydroxy-methotrexate in rabbits after multiple-dose infusion.
    Chen ML; Chiou WL
    J Pharmacokinet Biopharm; 1983 Oct; 11(5):515-27. PubMed ID: 6668557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the antibiotics piperacillin, doxycycline, and tobramycin on the pharmacokinetics of methotrexate in rabbits.
    Iven H; Brasch H
    Cancer Chemother Pharmacol; 1986; 17(3):218-22. PubMed ID: 3742705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of piperacillin on the pharmacokinetics of methotrexate and 7-hydroxymethotrexate.
    Najjar TA; Abou-Auda HS; Ghilzai NM
    Cancer Chemother Pharmacol; 1998; 42(5):423-8. PubMed ID: 9771959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of methotrexate (MTX) and 7-hydroxymethotrexate (7-OH-MTX) in rats and evidence for the metabolism of MTX to 7-OH-MTX.
    Fahrig L; Brasch H; Iven H
    Cancer Chemother Pharmacol; 1989; 23(3):156-60. PubMed ID: 2924373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits.
    Iven H; Brasch H; Engster J
    Cancer Chemother Pharmacol; 1985; 15(2):115-20. PubMed ID: 4017160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits after intravenous administration.
    Chen ML; Chiou WL
    J Pharmacokinet Biopharm; 1983 Oct; 11(5):499-513. PubMed ID: 6668556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A specific HPLC assay to determine the pharmacokinetics of methotrexate in patients.
    Chen ML; McGuire WP; Lad TE; Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):1-6. PubMed ID: 6698654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No influence of enzyme inhibitors on the hydroxylation of methotrexate in rats.
    Yu D; Brasch H; Iven H
    Cancer Lett; 1989 Nov; 48(2):153-6. PubMed ID: 2819703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate.
    Breithaupt H; Küenzlen E
    Cancer Treat Rep; 1982 Sep; 66(9):1733-41. PubMed ID: 6956440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic interaction between methotrexate and 4'-(9-acridinylamino)methanesulfon-M-anisidide in the rabbit.
    Lee YJ; Chan KK
    Cancer Res; 1988 Sep; 48(18):5106-11. PubMed ID: 3409236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of renal tubular transport of methotrexate by probenecid.
    Bourke RS; Chheda G; Bremer A; Watanabe O; Tower DB
    Cancer Res; 1975 Jan; 35(1):110-6. PubMed ID: 1109785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of transtubular transport inhibitors in the renal excretion of uric acid in the rat].
    Boudry JF
    Pflugers Arch; 1971; 328(4):279-91. PubMed ID: 5107270
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of methotrexate elimination and interaction with indomethacin and flurbiprofen in the isolated perfused rat kidney.
    Statkevich P; Fournier DJ; Sweeney KR
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1118-24. PubMed ID: 8509997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation and elimination of 7-hydroxymethotrexate in the rat in vivo after methotrexate administration.
    Bremnes RM; Slørdal L; Wist E; Aarbakke J
    Cancer Res; 1989 May; 49(9):2460-4. PubMed ID: 2706634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrazinoate excretion in the chimpanzee. Relation to urate disposition and the actions of uricosuric drugs.
    Fanelli GM; Weiner IM
    J Clin Invest; 1973 Aug; 52(8):1946-57. PubMed ID: 4719671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles.
    Roch-Ramel F; Guisan B; Diezi J
    J Pharmacol Exp Ther; 1997 Feb; 280(2):839-45. PubMed ID: 9023298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of probenecid on ventricular cerebrospinal fluid methotrexate pharmacokinetics after intralumbar administration in nonhuman primates.
    Salzer W; Widemann B; McCully C; Adamson PC; Balis FM
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):235-40. PubMed ID: 11592346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal and hepatic toxicity after high-dose 7-hydroxymethotrexate in the rat.
    Smeland E; Bremnes RM; Andersen A; Jaeger R; Eide TJ; Huseby NE; Aarbakke J
    Cancer Chemother Pharmacol; 1994; 34(2):119-24. PubMed ID: 8194163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.